Immunocompromised patients:
Patients with a known congenital or acquired immunodeficiency.
Patients who received chemotherapy less than 6 weeks ago.
Patients who received corticosteroids in the last 6 weeks.
Patients who received immunosuppressive medication in the last 6 weeks (e.g. cyclosporin, cyclophosphamide, azathioprine).
Patients with chronic obstructive pulmonary disease who are on systemic corticosteroids.
Patients who require intensive care unit treatment.
Patients with tropical worm infection.
Patients with dexamethasone intolerance.
Pregnant and breastfeeding women.

NCT01743755_exc_T1
Condition
Immunocompromised
NCT01743755_exc_T2
Condition
immunodeficiency
NCT01743755_exc_T3
Qualifier
acquired
NCT01743755_exc_T4
Qualifier
congenital
NCT01743755_exc_T5
Scope
congenital or acquired
NCT01743755_exc_T6
Procedure
chemotherapy
NCT01743755_exc_T7
Temporal
less than 6 weeks ago
NCT01743755_exc_T8
Drug
corticosteroids
NCT01743755_exc_T9
Temporal
in the last 6 weeks
NCT01743755_exc_T10
Procedure
immunosuppressive medication
NCT01743755_exc_T11
Temporal
in the last 6 weeks
NCT01743755_exc_T12
Drug
cyclosporin
NCT01743755_exc_T13
Drug
cyclophosphamide
NCT01743755_exc_T14
Drug
azathioprine
NCT01743755_exc_T15
Scope
cyclosporin, cyclophosphamide, azathioprine
NCT01743755_exc_T16
Condition
chronic obstructive pulmonary disease
NCT01743755_exc_T17
Drug
systemic corticosteroids
NCT01743755_exc_T18
Visit
intensive care unit
NCT01743755_exc_T19
Condition
tropical worm infection
NCT01743755_exc_T20
Drug
dexamethasone
NCT01743755_exc_T21
Condition
intolerance